Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Cost of RevenueDepreciation ExpenseEBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsReceivables - NetReceivables - OtherShares Issued
Ratios

Akebia Therapeutics (AKBA) Shares Issued (2016 - 2025)

Akebia Therapeutics (AKBA) has disclosed Shares Issued for 10 consecutive years, with -$430000.0 as the latest value for Q3 2025.

  • Quarterly Shares Issued fell 102.11% to -$430000.0 in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $230000.0 through Dec 2025, down 40.26% year-over-year, with the annual reading at $230000.0 for FY2025, 40.26% down from the prior year.
  • Shares Issued for Q3 2025 was -$430000.0 at Akebia Therapeutics, down from $582000.0 in the prior quarter.
  • The five-year high for Shares Issued was $72.4 million in Q4 2021, with the low at -$20.0 million in Q4 2024.
  • Average Shares Issued over 5 years is $9.2 million, with a median of $800000.0 recorded in 2022.
  • Peak annual rise in Shares Issued hit 55017.65% in 2024, while the deepest fall reached 54811.76% in 2024.
  • Over 5 years, Shares Issued stood at $72.4 million in 2021, then plummeted by 90.26% to $7.1 million in 2022, then dropped by 4.91% to $6.7 million in 2023, then tumbled by 398.4% to -$20.0 million in 2024, then skyrocketed by 97.85% to -$430000.0 in 2025.
  • According to Business Quant data, Shares Issued over the past three periods came in at -$430000.0, $582000.0, and $78000.0 for Q3 2025, Q2 2025, and Q1 2025 respectively.